Therapeutic Plasmapheresis with Albumin Replacement in Alzheimer’s Disease and Chronic Progressive Multiple Sclerosis: A Review

Background: Reducing the burden of beta-amyloid accumulation and toxic autoimmunity-related proteins, one of the recognized pathophysiological markers of chronic and common neurological disorders such as Alzheimer’s disease (AD) and multiple sclerosis (MS), may be a valid alternative therapy to redu...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarro-Martínez, Rut, Cauli, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169443/
https://www.ncbi.nlm.nih.gov/pubmed/32059404
http://dx.doi.org/10.3390/ph13020028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169443/
https://www.ncbi.nlm.nih.gov/pubmed/32059404
http://dx.doi.org/10.3390/ph13020028

Ejemplares similares